Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab

This study has been completed.
Information provided by (Responsible Party):
Central European Cooperative Oncology Group Identifier:
First received: January 14, 2008
Last updated: February 17, 2016
Last verified: February 2016